Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.59
Delayed Data
As of Jan 19
 +0.05 / +3.25%
Today’s Change
1.54
Today|||52-Week Range
14.79
-9.66%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Scopa James Paul
Director
Sale11/15/202150,000$2.18$109.0K-26.73%
Machado Clarence Patrick
Director
Buy3/24/202110,000$9.92$99.2K-82.82%
Fischer Laurent
Buy3/24/202110,000$9.88$98.8K-82.82%
Soparkar Peter
N/A
Buy12/08/202125,000$1.91$47.8K-14.97%
Fischer Laurent
Buy12/09/202114,323$1.85$26.5K-13.59%
Fischer Laurent
Buy12/08/202110,677$1.79$19.1K-14.97%
Clark Julie /adverum/
Chief Medical Officer
Sale9/30/20214,766$2.17$10.3K-26.73%
Fischer Laurent
Gift8/06/2021680,000$0.00$0.00-35.89%
Soparkar Peter
N/A
Gift8/06/2021220,000$0.00$0.00-35.89%
Thedinga Angela
Chief Technology Officer
Gift8/06/2021150,000$0.00$0.00-35.89%
Page of 2